Literature DB >> 17878409

Dialogue between LKB1 and AMPK: a hot topic at the cellular pole.

Christelle Forcet1, Marc Billaud.   

Abstract

Disruption of cell architecture and change of energy metabolism are two traits of malignant cells. Yet, there was scant evidence that these two cancer hallmarks involved perturbations of a common signaling pathway. Enter LKB1, a kinase that is a tumor suppressor and that is an upstream activator of the adenosine monophosphate (AMP)-activated protein kinase (AMPK), a key sensor of cellular energy status. Four studies now reveal that LKB1 signals through AMPK to facilitate the formation of tight junctions and to maintain epithelial polarity. Thus, LKB1 appears to be a novel class of tumor suppressor that acts as an energy-sensing and polarity checkpoint.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17878409     DOI: 10.1126/stke.4042007pe51

Source DB:  PubMed          Journal:  Sci STKE        ISSN: 1525-8882


  17 in total

1.  An insight into the transcriptome of the digestive tract of the bloodsucking bug, Rhodnius prolixus.

Authors:  José M C Ribeiro; Fernando A Genta; Marcos H F Sorgine; Raquel Logullo; Rafael D Mesquita; Gabriela O Paiva-Silva; David Majerowicz; Marcelo Medeiros; Leonardo Koerich; Walter R Terra; Clélia Ferreira; André C Pimentel; Paulo M Bisch; Daniel C Leite; Michelle M P Diniz; João Lídio da S G V Junior; Manuela L Da Silva; Ricardo N Araujo; Ana Caroline P Gandara; Sébastien Brosson; Didier Salmon; Sabrina Bousbata; Natalia González-Caballero; Ariel Mariano Silber; Michele Alves-Bezerra; Katia C Gondim; Mário Alberto C Silva-Neto; Georgia C Atella; Helena Araujo; Felipe A Dias; Carla Polycarpo; Raquel J Vionette-Amaral; Patrícia Fampa; Ana Claudia A Melo; Aparecida S Tanaka; Carsten Balczun; José Henrique M Oliveira; Renata L S Gonçalves; Cristiano Lazoski; Rolando Rivera-Pomar; Luis Diambra; Günter A Schaub; Elói S Garcia; Patrícia Azambuja; Glória R C Braz; Pedro L Oliveira
Journal:  PLoS Negl Trop Dis       Date:  2014-01-09

Review 2.  Mechanisms of environmental chemicals that enable the cancer hallmark of evasion of growth suppression.

Authors:  Rita Nahta; Fahd Al-Mulla; Rabeah Al-Temaimi; Amedeo Amedei; Rafaela Andrade-Vieira; Sarah N Bay; Dustin G Brown; Gloria M Calaf; Robert C Castellino; Karine A Cohen-Solal; Annamaria Colacci; Nichola Cruickshanks; Paul Dent; Riccardo Di Fiore; Stefano Forte; Gary S Goldberg; Roslida A Hamid; Harini Krishnan; Dale W Laird; Ahmed Lasfar; Paola A Marignani; Lorenzo Memeo; Chiara Mondello; Christian C Naus; Richard Ponce-Cusi; Jayadev Raju; Debasish Roy; Rabindra Roy; Elizabeth P Ryan; Hosni K Salem; A Ivana Scovassi; Neetu Singh; Monica Vaccari; Renza Vento; Jan Vondráček; Mark Wade; Jordan Woodrick; William H Bisson
Journal:  Carcinogenesis       Date:  2015-06       Impact factor: 4.944

Review 3.  Targeting the LKB1 tumor suppressor.

Authors:  Rui-Xun Zhao; Zhi-Xiang Xu
Journal:  Curr Drug Targets       Date:  2014-01       Impact factor: 3.465

Review 4.  Metformin: a new option in cancer treatment.

Authors:  Cristóbal Belda-Iniesta; Olga Pernía; Rafael Simó
Journal:  Clin Transl Oncol       Date:  2011-06       Impact factor: 3.405

5.  Hereditary hamartomatous polyposis syndromes: understanding the disease risks as children reach adulthood.

Authors:  Michael Manfredi
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-03

6.  Regulation of bile canalicular network formation and maintenance by AMP-activated protein kinase and LKB1.

Authors:  Dong Fu; Yoshiyuki Wakabayashi; Yasuo Ido; Jennifer Lippincott-Schwartz; Irwin M Arias
Journal:  J Cell Sci       Date:  2010-09-07       Impact factor: 5.285

7.  LKB1 regulates PRMT5 activity in breast cancer.

Authors:  Hanine Lattouf; Loay Kassem; Julien Jacquemetton; Ali Choucair; Coralie Poulard; Olivier Trédan; Laura Corbo; Mona Diab-Assaf; Nader Hussein; Isabelle Treilleux; Muriel Le Romancer
Journal:  Int J Cancer       Date:  2018-10-31       Impact factor: 7.396

8.  The apical (hPepT1) and basolateral peptide transport systems of Caco-2 cells are regulated by AMP-activated protein kinase.

Authors:  Myrtani Pieri; Helen C Christian; Robert J Wilkins; C A R Boyd; David Meredith
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-04-29       Impact factor: 4.052

9.  Adenosine Monophosphate-Activated Protein Kinase (AMPK) as a New Target for Antidiabetic Drugs: A Review on Metabolic, Pharmacological and Chemical Considerations.

Authors:  Arie Gruzman; Gali Babai; Shlomo Sasson
Journal:  Rev Diabet Stud       Date:  2009-05-10

10.  Activation of an AMP-activated protein kinase is involved in post-diapause development of Artemia franciscana encysted embryos.

Authors:  Xiao-Jing Zhu; Jie-Qiong Dai; Xin Tan; Yang Zhao; Wei-Jun Yang
Journal:  BMC Dev Biol       Date:  2009-03-16       Impact factor: 1.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.